The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Rowan Atkinson slipped back into character for the 25th anniversary of Mr Bean and took his mini for a spin outside Buckingham Palace.
The former head of security for Rebekah Brooks has said that he will release details that will "shock everybody" about News International.
Doctors say they cannot do anything for little Abigail Jones who was born with brain cancer and Down Syndrome so every moment is precious.